Program
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Odyssey Therapeutics, Inc.

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Announces Oversubscribed $213 Million Series D Financing to Advance Clinical Pipeline for Autoimmune Diseases
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics to Present New Data on its Clinical-Stage RIPK2 Scaffolding Inhibitor, OD-07656, at the American College of Gastroenterology (ACG) Annual Scientific Meeting 2024
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Appoints Biopharma Veterans Timothy P. Walbert and Ian F. Smith to its Board of Directors
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Appoints Preeminent Chemist Dr. William Roush as Executive Vice President and Head of Small Molecule Research
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Appoints Julie Clauss as Chief Operating Officer and Christopher Butler as SVP, Head of Chemistry
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Announces $101 Million Series C Financing
From Odyssey Therapeutics, Inc.
Via Business Wire
Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer
From Odyssey Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.